United Kingdom

People: Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

14 Jun 2019
Change (% chg)

$0.04 (+0.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Franchi, Jean 

Ms. Jean M. Franchi is no longer Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer of the company., effective June 28, 2019. Ms. Franchi previously served as Chief Financial Officer, Treasurer and Secretary at Dimension Therapeutics, Inc., a biotechnology company, from August 2015 to July 2017. From February 2012 to July 2015, Ms. Franchi served as Chief Financial Officer at Good Start Genetics, Inc., a molecular genetics information company. From 1995 to 2011, Ms. Franchi held various positions at Sanofi Genzyme, a global pharmaceutical company, including Senior Vice President of Corporate Finance, Senior Vice President of Business Unit Finance, Vice President of Finance and Controller, Product Line and International Group. Ms. Franchi holds a B.B.A. from Hofstra University and successfully completed the Uniform CPA Examination.

Basic Compensation

Total Annual Compensation, USD 292,026
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 348,565
Fiscal Year Total, USD 640,591

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --